AU Patent

AU2023376163A1 — Galantamine minitablets

Assigned to Rejuvenate Biomed NV · Expires 2025-05-29 · 1y expired

What this patent protects

The present invention relates to a method for obtaining galantamine minitablets, the minitablets obtainable by the method, and the use of these minitablets as a mono-therapeutic, or in combination with other active pharmaceuticals.

USPTO Abstract

The present invention relates to a method for obtaining galantamine minitablets, the minitablets obtainable by the method, and the use of these minitablets as a mono-therapeutic, or in combination with other active pharmaceuticals.

Drugs covered by this patent

acoramidis-hydrochloride (ACORAMIDIS HYDROCHLORIDE)

Patent Metadata

Patent number: AU2023376163A1
Jurisdiction: AU
Classification: —
Expires: 2025-05-29
Drug substance claim: No
Drug product claim: No
Assignee: Rejuvenate Biomed NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.